Vertex Pharmaceuticals (VRTX) Cash from Operations (2009 - 2026)
Vertex Pharmaceuticals (VRTX) posted Cash from Operations of $1.1 billion for Q2 2026, down 21.2% on a QoQ basis from $1.4 billion in Q1 2026, and up 4.87% year-over-year from $1.1 billion in Q2 2025.
Powered by 
Analysis
Vertex Pharmaceuticals (VRTX) Cash from Operations (2009 - 2026) Analysis & Trends
Vertex Pharmaceuticals has reported Cash from Operations for 18 years, with the latest figure at $1.1 billion in Q2 2026.
- On a quarterly basis, Cash from Operations rose 4.87% year-over-year to $1.1 billion in Q2 2026; TTM through Jun 2026 was $4.3 billion, a 11.61% increase from a year earlier, with the FY2025 full-year figure at $3.6 billion, up 837.19% from the prior year.
- Cash from Operations was $1.1 billion for Q2 2026 at Vertex Pharmaceuticals, down from $1.4 billion in the prior quarter.
- The five-year high for Cash from Operations was $1.4 billion in Q1 2026, with the low at -$3.8 billion in Q2 2024.
- Average Cash from Operations over 5 years is $742.2 million, with a median of $1.1 billion recorded in 2022.
- The sharpest annual moves came in 2022 and 2024: Cash from Operations jumped 670.76% in 2022, then plunged 430.89% in 2024.
- Over 5 years, Cash from Operations stood at $1.1 billion in 2022, then sank by 78.25% to $234.6 million in 2023, then surged by 149.19% to $584.6 million in 2024, then slipped by 14.81% to $498.0 million in 2025, then soared by 125.98% to $1.1 billion in 2026.
- The last three Cash from Operations figures came in at $1.1 billion (Q2 2026), $1.4 billion (Q1 2026), and $498.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | 8.62 Bn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | 3.44 Bn |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | 5.37 Bn |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | 5.88 Bn |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | 2.87 Bn |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | 4.00 Bn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | 3.57 Bn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | 835.00 Mn |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | 1.13 Bn |
| 10 | Bristol Myers Squibb | 124.95 Bn | 113.89 Bn | 9.25 Bn | 3.39 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.13 Bn |
| Mar 31, 2026 | 1.43 Bn |
| Dec 31, 2025 | 498.00 Mn |
| Sep 30, 2025 | 1.24 Bn |
| Jun 30, 2025 | 1.07 Bn |
| Mar 31, 2025 | 818.90 Mn |
| Dec 31, 2024 | 584.60 Mn |
| Sep 30, 2024 | 1.37 Bn |
| Jun 30, 2024 | -3.75 Bn |
| Mar 31, 2024 | 1.31 Bn |
| Dec 31, 2023 | 234.60 Mn |
| Sep 30, 2023 | 1.27 Bn |
| Jun 30, 2023 | 1.13 Bn |
| Mar 31, 2023 | 899.90 Mn |
| Dec 31, 2022 | 1.08 Bn |
| Sep 30, 2022 | 955.50 Mn |
| Jun 30, 2022 | 1.14 Bn |
| Mar 31, 2022 | 956.20 Mn |
| Dec 31, 2021 | 995.00 Mn |
| Sep 30, 2021 | 927.20 Mn |
API Access
Vertex Pharmaceuticals Cash from Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-operations&ticker=VRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-operations", "ticker": "VRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-operations&ticker=VRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();